Dhanashree Mundhe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dhanashree Mundhe has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Neta Erez
Department of Pathology, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
16 shared publications - Noam Cohen
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
16 shared publications - Nour Ershaid
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
16 shared publications - Omer Adler
Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
16 shared publications - Oshrat Levi-Galibov
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
16 shared publications - Rina Wassermann
Department of Biomolecular Sciences, Weizmann Institute of Science, Tel Aviv, Israel
16 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary Table 1 showing list of proteins detected in protein array
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary Table 1 showing list of proteins detected in protein array
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 6
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 6
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 1
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 1
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 4
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Supplementary data to Figure 4
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Metastatic cancer is largely incurable and is the main cause of cancer-related deaths. The metastatic microenvironment facilitates formation of metastases. Cancer-associated fibroblasts (CAF) are crucial players in generating a hospitable metastatic niche by mediating an inflammatory microenvironment. Fibroblasts also play a central role in modifying the architecture and stiffness of the extracellular matrix (ECM). Resolving the early changes in the metastatic niche could help identify approaches to inhibit metastatic progression. Here, we demonstrate in mouse models of spontaneous breast cancer pulmonary metastasis that fibrotic changes and rewiring of lung fibroblasts occurred at premetastatic stages, suggesting systemic influence by the primary tumor. Activin A (ActA), a TGFβ superfamily member, was secreted from breast tumors and its levels in the blood were highly elevated in tumor-bearing mice. ActA upregulated the expression of profibrotic factors in lung fibroblasts, leading to enhanced collagen deposition in the lung premetastatic niche. ActA signaling was functionally important for lung metastasis, as genetic targeting of ActA in breast cancer cells significantly attenuated lung metastasis and improved survival. Moreover, high levels of ActA in human patients with breast cancer were associated with lung metastatic relapse and poor survival. This study uncovers a novel mechanism by which breast cancer cells systemically rewire the stromal microenvironment in the metastatic niche to facilitate pulmonary metastasis.Significance:ActA mediates cross-talk between breast cancer cells and cancer-associated fibroblasts in the lung metastatic niche that enhances fibrosis and metastasis, implicating ActA as a potential therapeutic target to inhibit metastatic relapse.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Breast Cancer–Secreted Factors Promote Lung Metastasis by Signaling Systemically to Induce a Fibrotic Premetastatic Niche
Metastatic cancer is largely incurable and is the main cause of cancer-related deaths. The metastatic microenvironment facilitates formation of metastases. Cancer-associated fibroblasts (CAF) are crucial players in generating a hospitable metastatic niche by mediating an inflammatory microenvironment. Fibroblasts also play a central role in modifying the architecture and stiffness of the extracellular matrix (ECM). Resolving the early changes in the metastatic niche could help identify approaches to inhibit metastatic progression. Here, we demonstrate in mouse models of spontaneous breast cancer pulmonary metastasis that fibrotic changes and rewiring of lung fibroblasts occurred at premetastatic stages, suggesting systemic influence by the primary tumor. Activin A (ActA), a TGFβ superfamily member, was secreted from breast tumors and its levels in the blood were highly elevated in tumor-bearing mice. ActA upregulated the expression of profibrotic factors in lung fibroblasts, leading to enhanced collagen deposition in the lung premetastatic niche. ActA signaling was functionally important for lung metastasis, as genetic targeting of ActA in breast cancer cells significantly attenuated lung metastasis and improved survival. Moreover, high levels of ActA in human patients with breast cancer were associated with lung metastatic relapse and poor survival. This study uncovers a novel mechanism by which breast cancer cells systemically rewire the stromal microenvironment in the metastatic niche to facilitate pulmonary metastasis.Significance:ActA mediates cross-talk between breast cancer cells and cancer-associated fibroblasts in the lung metastatic niche that enhances fibrosis and metastasis, implicating ActA as a potential therapeutic target to inhibit metastatic relapse.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S3 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 6
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 6
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary Table 1 showing list of proteins detected in protein array
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary Table 1 showing list of proteins detected in protein array
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary Table 1 showing list of proteins detected in protein array
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary Table 1 showing list of proteins detected in protein array
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 1
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 1
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Figure S2 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 4
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche
Supplementary data to Figure 4